exs74539
Small Cell Carcinoma
Explore 18 assets in Small Cell Carcinoma →Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.UNKNOWNPhase 1
—
Rating in progress
exs74539 in Small Cell Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active